Atossa Genetics Inc. Press Releases

ATOS 
$5.17
*  
0.09
  negative  
1.71%
Get ATOS Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference
05/17/2013 8:00AM - PR Newswire

Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
05/15/2013 8:30AM - Market Wire

Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel
05/14/2013 8:30AM - Market Wire

Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
05/02/2013 9:00AM - PR Newswire

Atossa Genetics Signs Distribution Agreement With Millennium HealthCare
05/02/2013 9:00AM - Market Wire

Atossa Genetics to Exhibit at American Congress of Obstetrics and Gynecology Meeting
04/29/2013 8:30AM - Market Wire

Atossa Genetics: New Recommendations for Preventive Drug Treatment for Breast Cancer Are Helpful but Incomplete
04/23/2013 10:00AM - Market Wire

Atossa Genetics to Present at FSX San Francisco Investor Conference
04/23/2013 8:00AM - Market Wire

Atossa Genetics to Provide ForeCYTE Breast Health Test to Two Leading Breast Centers in Texas
04/16/2013 8:30AM - Market Wire

Atossa Genetics Launches Nationwide Awareness Program for Breast Cancer Prevention Test
04/15/2013 8:30AM - Market Wire

Atossa Genetics Announces $30 Million At-the-Market Common Stock Purchase Agreement With Aspire Capital, LLC
03/28/2013 8:05AM - Market Wire

Atossa Genetics Reports 2012 Results and Operating Highlights
03/28/2013 8:00AM - Market Wire

Atossa Genetics Announces National Agreement With Network Provider FedMed
03/13/2013 8:30AM - Market Wire

Atossa Genetics to Present at the 25th Annual ROTH Conference
03/06/2013 10:15AM - Market Wire

Atossa Genetics Receives Warning Letter From the Food and Drug Administration
02/25/2013 8:30AM - Business Wire